CURATE.AI Optimized Modulation for Multiple Myeloma
Clinical trial NCT03759093 · UNKNOWN
Trial details
- NCT number
- NCT03759093
- Sponsor
- National University Hospital, Singapore
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-10
- Primary completion
- 2025-09-10
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.